Related Experiment Videos
The hairpin ribozyme: discovery, two-dimensional model, and development for gene therapy
1Department of Biological Sciences, Northern Illinois University, DeKalb 60115, USA.
Progress in Nucleic Acid Research and Molecular Biology
|October 6, 1997
Summary
The hairpin ribozyme, a highly efficient RNA enzyme, was engineered for gene therapy. It effectively targets and cleaves HIV-1 RNA, showing promise as a novel AIDS therapeutic in clinical trials.
Area of Science:
- Molecular Biology
- Biochemistry
- RNA Catalysis
Background:
- The hairpin ribozyme is a small, efficient catalytic RNA molecule.
- Its catalytic domain was identified from a plant viral satellite RNA.
Purpose of the Study:
- To review the discovery, characterization, and structural determination of the hairpin ribozyme.
- To detail its application in human gene therapy for AIDS treatment.
Main Methods:
- Biochemical characterization and mutagenesis to determine the ribozyme's 2D structure.
- Design of ribozymes to target and cleave specific RNA sequences, including HIV-1.
- In vitro and in vivo testing of designed ribozymes against HIV-1.
Main Results:
- The hairpin ribozyme possesses a four-helix structure with 18 base pairs and five loops.
- It exhibits high catalytic efficiency and specific substrate recognition.
- Two designed ribozymes demonstrated significant inhibition of HIV-1 gene expression and replication in vitro and in vivo.
Conclusions:
- The hairpin ribozyme is a potent tool for gene therapy.
- Engineered hairpin ribozymes show significant therapeutic potential against HIV-1.
- These ribozymes are poised to be the first to enter human clinical trials as drugs.